News

Researchers have developed a DNA enzyme that can distinguish between two RNA strands inside a cell and cut the disease-associated strand while leaving the healthy strand intact.

Targeting opioid receptor pathway could treat pain without addiction or hallucinations.

Breakthroughs will enable exploration of Earth’s biochemical past, with hopes of discovering new therapeutic molecules.

There’s a strong link between psychedelic drugs and our vision. Trippy details, unexpected saccades and pupil dilation are all linked to taking compounds like LSD, magic mushrooms and DMT. But a new case report may be the first detailed documentation of a psychedelic temporarily reversing a diagnosis of color blindness.

Researchers have developed an artificial intelligence system that can create proteins not found in nature using generative diffusion.

A small group of patients with Type 2 diabetes significantly improved their long-term blood sugar levels when treated with high-dose tadalafil, but repetition in a larger study over a longer period is needed.

Nearly 90 percent of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective.

Pharmaceutical giant Eli Lilly and Company has announced encouraging data from its Phase 3 study of Alzheimer’s drug donanemab, a monoclonal antibody that Lilly claims slowed trial participants’ cognitive decline by 35%.

University of Queensland researchers have identified a unique pain pathway targeted by a notorious Australian stinging tree and say it could point the way to new, non-opioid pain relief.

A new research study, which analyzed the genetic data of almost 34,000 people, highlights potential safety concerns around women taking the anti-osteoporosis drug romosozumab.